Suppr超能文献

淋巴细胞外渗的分子机制。III. 百日咳毒素诱导的淋巴细胞外渗潜能丧失并非通过蛋白激酶C的激活介导。

Molecular mechanisms of lymphocyte extravasation. III. The loss of lymphocyte extravasation potential induced by pertussis toxin is not mediated via the activation of protein kinase C.

作者信息

Huang K, Im S Y, Samlowski W E, Daynes R A

机构信息

Department of Pathology, University of Utah Medical School, Salt Lake City 84132.

出版信息

J Immunol. 1989 Jul 1;143(1):229-38.

PMID:2732469
Abstract

The present study evaluated whether protein kinase C (PKC) activation was involved in the lymphocytosis promoting properties of pertussis toxin (Ptx). The exposure of mouse lymphocytes to phorbol esters (as a means to selectively activate PKC) caused a depression in their subsequent capacity to localize into lymph nodes and Peyer's patches in vivo. This pattern of inhibition was quite similar to that observed with lymphocytes treated with Ptx. The mechanisms responsible for the observed decreases in localization to lymphoid organs caused by these two agents, however, appeared to be distinct. Exposure of lymphocytes to PMA was followed by a time and dosage-dependent decrease in the surface density of MEL-14 defined homing receptors. Ptx-treated lymphocytes retained normal density of this homing receptor. Consequently, PMA-treated lymphocytes lost their capacity to bind to high-endothelial venules in in vitro lymph node binding assays while Ptx-treated cells retained normal high-endothelial venule binding potential. We conclude from this study that: 1) the activation of PKC in lymphocytes by PMA can alter their recirculation properties via mechanisms that diminish their expression of surface receptors which support extravasation into lymph node and mucosal lymphoid tissues, and 2) even though Ptx has been reported to elevate the rate of inositol phosphate turnover in lymphocytes, the loss of extravasation potential of Ptx-treated lymphocytes is not mediated via the modification of surface homing receptors as observed in cells exposed to the known PKC activator, PMA.

摘要

本研究评估了蛋白激酶C(PKC)激活是否参与百日咳毒素(Ptx)促进淋巴细胞增多的特性。将小鼠淋巴细胞暴露于佛波酯(作为选择性激活PKC的手段)会导致其随后在体内定位于淋巴结和派伊尔结的能力下降。这种抑制模式与用Ptx处理的淋巴细胞所观察到的模式非常相似。然而,这两种试剂导致淋巴细胞向淋巴器官定位减少的机制似乎不同。淋巴细胞暴露于PMA后,MEL-14定义的归巢受体的表面密度会出现时间和剂量依赖性下降。Ptx处理的淋巴细胞保留了这种归巢受体的正常密度。因此,在体外淋巴结结合试验中,PMA处理的淋巴细胞失去了与高内皮微静脉结合的能力,而Ptx处理的细胞保留了正常的高内皮微静脉结合潜力。我们从这项研究中得出结论:1)PMA对淋巴细胞中PKC的激活可通过降低其支持向淋巴结和黏膜淋巴组织渗出的表面受体表达的机制来改变其再循环特性;2)尽管据报道Ptx可提高淋巴细胞中肌醇磷酸周转率,但Ptx处理的淋巴细胞渗出潜力的丧失并非通过修饰表面归巢受体介导,这与暴露于已知PKC激活剂PMA的细胞中观察到的情况不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验